Oak Ridge Investments LLC Eli Lilly & CO Transaction History

Oak Ridge Investments LLC

$1.05 Billion
Q2 2024

A detailed history of Oak Ridge Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Oak Ridge Investments LLC holds 48,396 shares of LLY stock, worth $42.5 Million. This represents 4.18% of its overall portfolio holdings.

Number of Shares

48,396

Previous 55,603 12.96%

Holding current value

$42.5 Million

Previous $43.3 Million 1.29%

% of portfolio

4.18%

Previous 4.37%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $5.22 Million - $6.55 Million	-7,207 Reduced 12.96%	48,396 $43.8 Million
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $1.2 Million - $1.61 Million	2,030 Added 3.79%	55,603 $43.3 Million
Q4 2023 Jan 16, 2024	BUY	$525.19 - $619.13 $407,547 - $480,444	776 Added 1.47%	53,573 $31.2 Million
Q3 2023 Oct 30, 2023	BUY	$434.7 - $599.3 $653,354 - $900,747	1,503 Added 2.93%	52,797 $28.4 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $297,427 - $397,695	-848 Reduced 1.63%	51,294 $24.1 Million
Q1 2023 Apr 14, 2023	SELL	$310.63 - $364.82 $71,755 - $84,273	-231 Reduced 0.44%	52,142 $17.9 Million
Q4 2022 Jan 24, 2023	SELL	$321.55 - $374.67 $751,140 - $875,229	-2,336 Reduced 4.27%	52,373 $0
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $661,446 - $753,787	-2,231 Reduced 3.92%	54,709 $17.7 Million
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $495,581 - $581,886	-1,778 Reduced 3.03%	56,940 $18.5 Million
Q1 2022 Apr 22, 2022	SELL	$234.69 - $291.66 $835,731 - $1.04 Million	-3,561 Reduced 5.72%	58,718 $16.8 Million
Q4 2021 Feb 01, 2022	SELL	$224.85 - $279.04 $379,996 - $471,577	-1,690 Reduced 2.64%	62,279 $17.2 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $217,168 - $267,255	-980 Reduced 1.51%	63,969 $14.8 Million
Q2 2021 Jul 30, 2021	SELL	$180.55 - $233.54 $206,910 - $267,636	-1,146 Reduced 1.73%	64,949 $14.9 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $113 Million - $146 Million	-688,089 Reduced 91.24%	66,095 $12.3 Million
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $113 Million - $146 Million	688,271 Added 1044.21%	754,184 $141 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $3.23 Million - $4.28 Million	-24,774 Reduced 27.32%	65,913 $11.1 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $217,867 - $252,003	-1,490 Reduced 1.62%	90,687 $13.4 Million
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $211,587 - $254,643	-1,551 Reduced 1.65%	92,177 $15.1 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $960,852 - $1.19 Million	-8,071 Reduced 7.93%	93,728 $13 Million
Q4 2019 Feb 05, 2020	SELL	$106.92 - $132.43 $668,463 - $827,952	-6,252 Reduced 5.79%	101,799 $13.4 Million
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $442,217 - $481,018	-4,141 Reduced 3.69%	108,051 $12.1 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $918,781 - $1.07 Million	-8,293 Reduced 6.88%	112,192 $12.4 Million
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $254,232 - $299,249	-2,284 Reduced 1.86%	120,485 $15.6 Million
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $182,571 - $204,535	-1,724 Reduced 1.38%	122,769 $14.2 Million
Q3 2018 Nov 07, 2018	SELL	$85.86 - $107.31 $537,483 - $671,760	-6,260 Reduced 4.79%	124,493 $13.4 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $296,895 - $340,743	-3,922 Reduced 2.91%	130,753 $11.2 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $4.05 Million - $4.79 Million	-54,641 Reduced 28.86%	134,675 $10.4 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $639,132 - $685,542	-7,800 Reduced 3.96%	189,316 $16 Million
Q3 2017 Nov 07, 2017	SELL	$77.07 - $85.54 $1.57 Million - $1.75 Million	-20,401 Reduced 9.38%	197,116 $16.9 Million
Q2 2017 Aug 10, 2017	BUY	N/A	217,517	217,517 $17.9 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.

Account

Oak Ridge Investments LLC Eli Lilly & CO Transaction History